PRICE INQUIRY No. SEMA/19/2023/API - being conducted as a market assessment study

PRICE INQUIRY No. SEMA/19/2023/API - being conducted as a market assessment study

In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor agonist class for the treatment of type 2 diabetes”,” funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a bid for the purchase and supply of the active pharmaceutical ingredient Semaglutide. Details of the price inquiry can be found in the documents attached below.

go back